Literature DB >> 8590980

Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.

T Kinonen1, M Pasanen, J Gynther, A Poso, T Järvinen, E Alhava, R O Juvonen.   

Abstract

1. We have shown earlier that pilocarpine strongly inhibits mouse and human liver coumarin 7-hydroxylase activity of CYP 2A and pentoxyresorufin O-deethylase activity of CYP 2B in vitro. Since pilocarpine, like coumarin, contains a lactone structure we have studied in more detail its inhibitory potency on mouse and human liver coumarin 7-hydroxylation. 2. Pilocarpine was a competitive inhibitor of coumarin 7-hydroxylase in vitro both in mouse and human liver microsomes although it was not a substrate for CYP 2A5. Ki values were similar, 0.52 +/- 0.22 microM in mice and 1.21 +/- 0.51 microM in human liver microsomes. 3. Pilocarpine induced a type II difference spectrum in mouse, human and recombinant CYP 2A5 yeast cell microsomes, with Ka values of 3.7 +/- 1.6, 1.6 +/- 1.1 and 1.5 +/- 0.1 microM, respectively. 4. Increase in pH of the incubation medium from pH 6 to 7.5 increased the potency of inhibition of coumarin 7-hydroxylation by pilocarpine. 5. Superimposition of pilocarpine and coumarin in such a way that their carbonyls, ring oxygens and the H-7' of coumarin and N-3 of pilocarpine overlap yielded a common molecular volume of 82%. 6. The results indicate that pilocarpine is a competitive inhibitor and has a high affinity for mouse CYP 2A5 and human CYP 2A6. In addition the immunotype nitrogen of pilocarpine is coordinated towards the haem iron in these P450s.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590980      PMCID: PMC1909112          DOI: 10.1111/j.1476-5381.1995.tb17217.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy.

Authors:  C R Jefcoate
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

Review 3.  Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man.

Authors:  A J Cohen
Journal:  Food Cosmet Toxicol       Date:  1979-06

4.  Potent inhibitory action of pilocarpine on hepatic drug metabolism.

Authors:  A Tsujimoto; T Doi; S Kojima
Journal:  Jpn J Pharmacol       Date:  1972-10

5.  A simple and sensitive assay of 7-ethoxycoumarin deethylation.

Authors:  A Aitio
Journal:  Anal Biochem       Date:  1978-04       Impact factor: 3.365

6.  Structural gene products of the Ah locus. Evidence for many unique P-450-mediated monooxygenase activities reconstituted from 3-methylcholanthrene-treated C57BL/6N mouse liver microsomes.

Authors:  M A Lang; D W Nebert
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

7.  Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes.

Authors:  J Mäenpää; H Sigusch; H Raunio; T Syngelmä; P Vuorela; H Vuorela; O Pelkonen
Journal:  Biochem Pharmacol       Date:  1993-03-09       Impact factor: 5.858

8.  Genetic variation in coumarin hydroxylase activity in the mouse (Mus musculus).

Authors:  A W Wood; A H Conney
Journal:  Science       Date:  1974-08-16       Impact factor: 47.728

9.  Determination of physicochemical properties, stability in aqueous solutions and serum hydrolysis of pilocarpic acid diesters.

Authors:  T Järvinen; P Suhonen; H Naumanen; A Urtti; P Peura
Journal:  J Pharm Biomed Anal       Date:  1991       Impact factor: 3.935

10.  The inhibition of CYP enzymes in mouse and human liver by pilocarpine.

Authors:  T Kimonen; R O Juvonen; E Alhava; M Pasanen
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

View more
  5 in total

1.  [Drug Treatment of Chronic Venous Diesease].

Authors:  Miloš D Pavlović
Journal:  Wien Med Wochenschr       Date:  2016-07-05

2.  Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine.

Authors:  Natasha M DeVore; Kathleen M Meneely; Aaron G Bart; Eva S Stephens; Kevin P Battaile; Emily E Scott
Journal:  FEBS J       Date:  2011-11-25       Impact factor: 5.542

3.  Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

Authors:  Yune-Fang Ueng; Chien-Chih Chen; Yu-Ting Chung; Tsung-Yun Liu; Yu-Ping Chang; Wei-Sheng Lo; Norie Murayama; Hiroshi Yamazaki; Pavel Souček; Gar-Yang Chau; Chin-Wen Chi; Ruei-Ming Chen; Ding-Tzai Li
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 4.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

Review 5.  Variation in CYP2A6 Activity and Personalized Medicine.

Authors:  Julie-Anne Tanner; Rachel F Tyndale
Journal:  J Pers Med       Date:  2017-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.